Bain Capital Public Equity Management II as of Sept. 30, 2019
Portfolio Holdings for Bain Capital Public Equity Management II
Bain Capital Public Equity Management II holds 51 positions in its portfolio as reported in the September 2019 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Docusign (DOCU) | 17.4 | $189M | 3.1M | 61.92 | |
Alibaba Group Holding (BABA) | 10.0 | $109M | 649k | 167.23 | |
Anaplan | 6.7 | $73M | 1.5M | 47.00 | |
Godaddy Inc cl a (GDDY) | 6.3 | $68M | 1.0M | 65.98 | |
Crown Holdings (CCK) | 5.7 | $62M | 944k | 66.06 | |
Ceridian Hcm Hldg (DAY) | 4.9 | $54M | 1.1M | 49.37 | |
Ball Corporation (BALL) | 4.2 | $46M | 627k | 72.81 | |
Voya Financial (VOYA) | 3.9 | $42M | 771k | 54.44 | |
Honeywell International (HON) | 3.4 | $37M | 220k | 169.20 | |
Mimecast | 2.9 | $32M | 882k | 35.67 | |
Fidelity National Information Services (FIS) | 2.7 | $30M | 224k | 132.76 | |
Wright Express (WEX) | 2.6 | $28M | 138k | 202.07 | |
Novartis (NVS) | 2.2 | $25M | 282k | 86.90 | |
United Technologies Corporation | 2.2 | $24M | 173k | 136.52 | |
Northrop Grumman Corporation (NOC) | 2.1 | $23M | 62k | 374.79 | |
Crane | 1.7 | $19M | 230k | 80.63 | |
Horizon Therapeutics | 1.6 | $17M | 625k | 27.23 | |
Sap (SAP) | 1.5 | $17M | 140k | 117.87 | |
National Vision Hldgs (EYE) | 1.5 | $16M | 676k | 24.07 | |
Dynavax Technologies (DVAX) | 1.4 | $15M | 4.8M | 3.14 | |
Children's Place Retail Stores (PLCE) | 1.3 | $14M | 184k | 76.99 | |
New York Times Company (NYT) | 1.3 | $14M | 491k | 28.48 | |
Uber Technologies (UBER) | 1.3 | $14M | 450k | 30.47 | |
E TRADE Financial Corporation | 1.2 | $13M | 304k | 43.69 | |
Iqvia Holdings (IQV) | 1.2 | $13M | 86k | 149.38 | |
Gs Acquisition Holdings Cl A Ord | 1.0 | $11M | 1.0M | 10.65 | |
Wynn Resorts (WYNN) | 0.9 | $10M | 92k | 108.71 | |
Science App Int'l (SAIC) | 0.8 | $8.8M | 101k | 87.35 | |
Peloton Interactive Inc cl a (PTON) | 0.7 | $7.5M | 300k | 25.10 | |
Meridian Ban | 0.7 | $7.0M | 375k | 18.75 | |
Cloudera | 0.6 | $6.1M | 687k | 8.86 | |
Sanofi-Aventis SA (SNY) | 0.5 | $5.7M | 123k | 46.33 | |
Ironwood Pharmaceuticals (IRWD) | 0.5 | $5.1M | 598k | 8.58 | |
Achillion Pharmaceuticals | 0.5 | $5.1M | 1.4M | 3.60 | |
salesforce (CRM) | 0.4 | $4.7M | 32k | 148.43 | |
Translate Bio | 0.4 | $4.1M | 417k | 9.91 | |
Synchrony Financial (SYF) | 0.3 | $3.7M | 108k | 34.09 | |
Affimed Therapeutics B V | 0.3 | $3.0M | 1.0M | 2.94 | |
Network Associates Inc cl a (NET) | 0.3 | $2.8M | 150k | 18.57 | |
General Dynamics Corporation (GD) | 0.2 | $2.7M | 15k | 182.73 | |
Medicines Company | 0.2 | $2.1M | 42k | 50.00 | |
iShares FTSE/Xinhua China 25 Index (FXI) | 0.1 | $1.5M | 21k | 73.51 | |
SPDR S&P Biotech (XBI) | 0.1 | $1.2M | 6.7k | 185.44 | |
Spdr S&p 500 Etf (SPY) | 0.1 | $811k | 3.0k | 273.99 | |
iShares Russell 2000 Index (IWM) | 0.1 | $598k | 1.9k | 323.24 | |
General Electric Company | 0.1 | $587k | 177k | 3.31 | |
Teva Pharmaceutical Industries (TEVA) | 0.0 | $308k | 12k | 25.18 | |
Boeing Company (BA) | 0.0 | $288k | 4.2k | 68.57 | |
Bristol Myers Squibb (BMY) | 0.0 | $221k | 4.6k | 48.04 | |
Proteostasis Therapeutics In | 0.0 | $172k | 202k | 0.85 | |
Curis | 0.0 | $125k | 56k | 2.24 |